0001209191-18-049721.txt : 20180905 0001209191-18-049721.hdr.sgml : 20180905 20180905204139 ACCESSION NUMBER: 0001209191-18-049721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180904 FILED AS OF DATE: 20180905 DATE AS OF CHANGE: 20180905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grigoriadis Dimitri E. CENTRAL INDEX KEY: 0001423838 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 181056512 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-04 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001423838 Grigoriadis Dimitri E. 12780 EL CAMINO REAL SAN DIEGO CA 92130 0 1 0 0 Chief Research Officer Common Stock 2018-09-04 4 M 0 13632 8.66 A 96574 D Common Stock 2018-09-04 4 M 0 11037 8.65 A 107611 D Common Stock 2018-09-04 4 M 0 5978 19.59 A 113589 D Common Stock 2018-09-04 4 M 0 2102 32.99 A 115691 D Incentive Stock Option 8.66 2018-09-04 4 M 0 13632 8.66 A 2022-01-12 Common Stock 13632 0 D Incentive Stock Option 8.65 2018-09-04 4 M 0 11037 8.65 A 2023-01-10 Common Stock 11037 0 D Incentive Stock Option 19.59 2018-09-04 4 M 0 5978 19.59 A 2024-01-16 Common Stock 5978 0 D Incentive Stock Option 32.99 2018-09-04 4 M 0 2102 32.99 A 2025-02-03 Common Stock 2102 2710 D Option granted January 12, 2012 and vested monthly over four years. Option granted January 10, 2013 and vested monthly over four years. Option granted January 16, 2014 and vested monthly over four years. Option granted February 3, 2015 and vests monthly over four years. /s/ Darin Lippoldt, Attorney-in-Fact 2018-09-05